GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 34 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,282 | -22.7% | 79,976 | 0.0% | 0.00% | – |
| Q2 2023 | $24,953 | -44.6% | 79,976 | -2.3% | 0.00% | – |
| Q1 2023 | $45,035 | -69.2% | 81,881 | -50.0% | 0.00% | – |
| Q4 2022 | $146,420 | -19.1% | 163,762 | +59.3% | 0.00% | – |
| Q3 2022 | $181,000 | -35.6% | 102,776 | +9.2% | 0.00% | – |
| Q2 2022 | $281,000 | -79.7% | 94,076 | -80.5% | 0.00% | – |
| Q1 2022 | $1,387,000 | -13.1% | 481,717 | -8.0% | 0.00% | – |
| Q4 2021 | $1,597,000 | -49.5% | 523,615 | +11.6% | 0.00% | – |
| Q3 2021 | $3,161,000 | -45.6% | 469,028 | +25.2% | 0.00% | – |
| Q2 2021 | $5,808,000 | – | 374,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silverleafe Capital Partners, LLC | 105,000 | $708,000 | 0.28% |
| Welch Group, LLC | 10,000 | $67,000 | 0.01% |
| Cubist Systematic Strategies, LLC | 33,703 | $227,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 14,260 | $96,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 15,000 | $101,000 | 0.00% |
| ExodusPoint Capital Management, LP | 22,200 | $150,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 162,823 | $1,097,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 51,100 | $344,000 | 0.00% |
| TimeScale Financial, Inc. | 549 | $4,000 | 0.00% |
| Hartford Financial Management Inc. | 500 | $3,000 | 0.00% |